Australia By William GreenNovember 12, 2025AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans AlphaTON’s Cyncado Therapeutics teams up with Australia’s ADDRI to launch a groundbreaking investigator-initiated mesothelioma trial of TT-4, perfectly complementing ongoing U.S. clinical efforts and accelerating the fight against cancer